News & Events
RGCC International Announces the Launch of InVyomma Plus: A Revolutionary Gut Microbiome Profiling Test
RGCC International is proud to announce the launch of its latest test, InVyomma Plus. The test is designed to…
RGCC International at DMCCB Basel Symposium 2025: Celebrating Excellence in Cancer Research
RGCC International is honored to have participated in the DMCCB Basel Symposium 2025.
As part of its Corporate Social Responsibility activities, RGCC International Donates CHF 15,000 to Universitäts-Kinderspital Zürich
As part of its ongoing commitment to Corporate Social Responsibility (CSR), RGCC International is proud to announce a donation…
RGCC and PERABOI Sign MOU for a Clinical Study on Circulating Tumor Cells in Breast Cancer
October 4th, 2024 – Bali, Indonesia: RGCC, a leader in advanced diagnostic technologies, and the Indonesian Association of Surgical…
RGCC SA laboratory in Greece receives prestigious certification from Japan’s Ministry Of Health, Labour and Welfare
Japan
RGCC SA is proud to announce that our state-of-the-art laboratory in Greece has been awarded the accreditation certificate of…